349 related articles for article (PubMed ID: 33212778)
1. Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature.
Montemurro N; Perrini P; Rapone B
Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33212778
[TBL] [Abstract][Full Text] [Related]
2. Type 2 Diabetes Mellitus and Glioblastoma Multiforme-Assessing Risk and Survival: Results of a Large Retrospective Study and Systematic Review of the Literature.
Barami K; Lyon L; Conell C
World Neurosurg; 2017 Oct; 106():300-307. PubMed ID: 28698089
[TBL] [Abstract][Full Text] [Related]
3. The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis.
Lu VM; Goyal A; Vaughan LS; McDonald KL
Clin Neurol Neurosurg; 2018 Jul; 170():165-169. PubMed ID: 29803727
[TBL] [Abstract][Full Text] [Related]
4. Association Between Perioperative Hyperglycemia and Survival in Patients With Glioblastoma.
Hagan K; Bhavsar S; Arunkumar R; Grasu R; Dang A; Carlson R; Cowles C; Arnold B; Potylchansky Y; Rahlfs TF; Lipski I; Walsh C; Jimenez F; Nguyen AT; Feng L; Cata JP
J Neurosurg Anesthesiol; 2017 Jan; 29(1):21-29. PubMed ID: 27438798
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients.
Welch MR; Grommes C
CNS Oncol; 2013 May; 2(3):237-46. PubMed ID: 25054464
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
7. Metformin influences progression in diabetic glioblastoma patients.
Adeberg S; Bernhardt D; Ben Harrabi S; Bostel T; Mohr A; Koelsche C; Diehl C; Rieken S; Debus J
Strahlenther Onkol; 2015 Dec; 191(12):928-35. PubMed ID: 26329695
[TBL] [Abstract][Full Text] [Related]
8. Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastoma.
Noch EK; Palma LN; Yim I; Bullen N; Qiu Y; Ravichandran H; Kim J; Rendeiro A; Davis MB; Elemento O; Pisapia DJ; Zhai K; LeKaye HC; Koutcher JA; Wen PY; Ligon KL; Cantley LC
Neuro Oncol; 2023 Dec; 25(12):2165-2176. PubMed ID: 37399061
[TBL] [Abstract][Full Text] [Related]
9. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
10. The Association Between Common Clinical Characteristics and Postoperative Morbidity and Overall Survival in Patients with Glioblastoma.
Liu W; Qdaisat A; Yeung J; Lopez G; Weinberg J; Zhou S; Cohen L; Bruera E; Yeung SJ
Oncologist; 2019 Apr; 24(4):529-536. PubMed ID: 30049883
[TBL] [Abstract][Full Text] [Related]
11. Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme.
Mayer A; Vaupel P; Struss HG; Giese A; Stockinger M; Schmidberger H
Strahlenther Onkol; 2014 Oct; 190(10):933-8. PubMed ID: 24938515
[TBL] [Abstract][Full Text] [Related]
12. Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme Phenotype.
Laviv Y; Sapirstein E; Kanner AA; Berkowitz S; Fichman S; Benouaich-Amiel A; Yust-Katz S; Kasper EE; Siegal T
Clin Pathol; 2023; 16():2632010X231207725. PubMed ID: 37920781
[TBL] [Abstract][Full Text] [Related]
13. Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma.
Derr RL; Ye X; Islas MU; Desideri S; Saudek CD; Grossman SA
J Clin Oncol; 2009 Mar; 27(7):1082-6. PubMed ID: 19139429
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of c-Met is Associated with Poor Prognosis in Glioblastoma Multiforme: A Systematic Review and Meta-Analyses.
Anton J; Sudibio S; Handoko H; Permata TBM; Kodrat H; Nuryadi E; Sofyan H; Susanto E; Mulyadi R; Aman RA; Gondhowiardjo S
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3075-3080. PubMed ID: 34710981
[TBL] [Abstract][Full Text] [Related]
16. Modifiable risk factors for glioblastoma: a systematic review and meta-analysis.
Yoshikawa MH; Rabelo NN; Telles JPM; Figueiredo EG
Neurosurg Rev; 2023 Jun; 46(1):143. PubMed ID: 37340151
[TBL] [Abstract][Full Text] [Related]
17. Ten-year survival in glioblastoma. A systematic review.
Tykocki T; Eltayeb M
J Clin Neurosci; 2018 Aug; 54():7-13. PubMed ID: 29801989
[TBL] [Abstract][Full Text] [Related]
18. Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis.
Revilla-Pacheco F; Rodríguez-Salgado P; Barrera-Ramírez M; Morales-Ruiz MP; Loyo-Varela M; Rubalcava-Ortega J; Herrada-Pineda T
Medicine (Baltimore); 2021 Jun; 100(25):e26432. PubMed ID: 34160432
[TBL] [Abstract][Full Text] [Related]
19. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
[TBL] [Abstract][Full Text] [Related]
20. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
Rong X; Yang W; Garzon-Muvdi T; Caplan JM; Hui X; Lim M; Huang J
Cancer; 2016 Oct; 122(20):3157-3165. PubMed ID: 27500668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
